Neuron-Specific Enolase (NSE), an enzyme released after neuronal damage, has been studied as a marker for brain injury including ischemic stroke [13], and NSE level correlates with a patient's clinical deficits and infarct volume [14, 15]. The gene discussed is ENO2; the disease is ischemic stroke.